Research Developments in Atopic Dermatitis
Research Developments in Atopic Dermatitis
Annenberg Center for Health Sciences at Eisenhower
Efficacy and Safety Trends with Continuous Longterm Use of Crisaborole Ointment 2% in Patients with Mild-to-Moderate Atopic Dermatitis
6 minutes Posted Sep 8, 2020 at 2:09 pm.
0:00
6:59
Download MP3
Show notes

The poster was presented by Dr. Lebwohl and colleagues at the 2020 American Academy of Dermatology virtual annual meeting. 

This audio commentary is provided by Dr. Steve Feldman.